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Side population (SP) cells are an enriched population of stem, and the existence of SP cells has been reported in human cancer
cell lines. In this study, we performed an SP analysis using 11 human cancer cell lines and conﬁrmed the presence of SP cells
in an embryonic carcinoma cell line, NEC8. NEC8 SP cells showed characteristics of cancer stem cells, such as high growth rate,
chemoresistanceandhighinvasiveness.TofurthercharacterizetheNEC8SPcells,weusedDNAmicroarrays.Among38,500genes,
we identiﬁed 12 genes that were over-expressed in SP cells and 1 gene that was over-expressed in non-SP cells. Among these 13
genes, we focused on GADD45b. GADD45b was over-expressed in non-SP cells, but the inhibition of GADD45b had no eﬀect
on non-SP cells. Paradoxically, the inhibition of GADD45b signiﬁcantly reduced the viability of NEC8 SP cells. The inhibition of
ABCG2, which determines the SP phenotype, had no eﬀect on the invasiveness of NEC8 SP cells, but the inhibition of GADD45b
signiﬁcantlyreducedinvasiveness.Theseresultssuggest thatGADD45b, butnotABCG2,mightdeterminethecancer stemcell-like
phenotype, such as chemoresistance and the high invasiveness of NEC8 SP cells, and might be a good therapeutic target.
1.Introduction
Stem cells, which have the ability to perpetuate themselves
through self-renewal and diﬀerentiation, are rare in normal
tissue. Several reports have shown that cancer cells also
contain a small subset of cancer stem cells (CSC) with
unlimited potential for self-renewal, and these cells drive
tumorigenesis. CSC are characterized by the ability to gen-
erate new heterogeneous tumors and the ability to develop
multidrug resistance [1, 2]. However, the characterization
of CSC remains insuﬃcient. The roots of CSC and the
mechanism of tumorigenesis are considered to originate
from the interaction of mutated somatic stem cells and
progenitor cells [3]. CSC are more important for cancer
therapy than other tumor cells because CSC might be
responsible for recurrence after cancer treatment. In other
words,clarifyingthemechanismsresponsiblefortheinvasive
growth and chemoresistance of CSC are key tasks for cancer
therapy, and CSC might be a good therapeutic target.
Side population (SP) cells were originally reported as
an enriched population of murine hematopoietic stem
cells identiﬁed using Hoechst 33342 dye and FACS [4].
Recent studies have shown that this phenotype depends
on the expression of ABCG2, an ATP-binding cassette
(ABC) transporter [5]. SP cells have been isolated from
many kinds of normal human tissues: prostate [6], limbal2 Stem Cells International
epithelium [7], mammary gland [8, 9], skin [10], and kidney
[11–13]. Recently, SP cells have also been isolated from
a variety of human cancer cell lines, including leukemia
[14], neuroblastoma [15], hepatoma [16, 17], colorectal
[17], thyroid [18], nasopharyngeal [19], and lung cancer
[20]. Moreover, cancer SP cells are reported to have stem
cell-like functions, such as chemoresistance to anticancer
drugs,clonogenicability,andtumorigenicity.Inotherwords,
cancerSPcellsarepromisingCSCandmightbeagoodtarget
for cancer therapy.
In this study, we ﬁrst tried to identify SP cells in human
cancer cell lines and found a signiﬁcant SP population in
the embryonic carcinoma cell line NEC8. Compared to non-
SP cells, the SP cells showed not only rapid growth and
chemoresistance, but also rapid invasive growth. To clarify
the mechanisms of the chemoresistance and invasive growth
ofSPcells,weperformedamicroarrayanalysis.Weidentiﬁed
13 genes that were diﬀerentially expressed between SP and
non-SPcells.Amongthe13genes,wefocusedonGADD45β.
GADD45β belongs to the growth arrest- and DNA damage-
inducible protein family and is related to NF-kB, which
is known to inﬂuence tumorigenesis, cancer cell survival,
apoptosis, invasion, and metastasis [21, 22]. GADD45β was
overexpressed in non-SP, but the knockdown of GADD45β
paradoxically reduced the cell viability of NEC8 SP cells, but
not of non-SP cells. Moreover, the invasive growth of NEC8
SP cells was reduced by the inhibition of GADD45β,b u t
not by the inhibition of ABCG2, which determines the SP
phenotype. Our results suggest that the CSC-like phenotype,
such as resistance to anticancer drugs and invasive growth,
might not only be determined by ABCG2, but also by
GADD45β.
2.MaterialsandMethods
2.1. Cell Cultures. Several human cancer cell lines were
used: kidney (ACHN, Caki-1, OS-RC-2, RCC10RGB),
prostate (DU145, LNCap.FGC, PC3), bladder (EJ-1,
RT4, T24), embryonic carcinoma (NEC8), and breast
cancer (MCF-7). OS-RC-2, LNCap.FGC and NEC8
were cultured in RPMI 1640 (Sigma-Aldrich, St. Louis,
http://www.sigmaaldrich.com). RCC10 RGB was cultured in
Dulbecco’s Modiﬁed Eagle’s Medium-low glucose (Sigma-
Aldrich). PC3 was cultured in F-12 Nutrient Mixture (Ham’s
F-12; Gibco, Grand Island, NY, http://www.invitrogen.com).
MCF-7 was maintained in Dulbecco’s modiﬁed Eagle’s
medium (Gibco) and the remaining cell lines were cultured
in minimal essential medium (Gibco). Each medium was
supplementedwith10%fetalbovineserum(Sigma-Aldrich).
Only ACHN was supplemented with 1% MEM Nonessential
Amino Acids Solution (Sigma). All the cells were incubated
at 37◦C in an atmosphere containing 5% CO2.A C H N ,
LNCap.FGC, and PC3 were obtained from Dainippon
Sumitomo Pharma (Osaka, http://www.ds-pharma.co.jp/).
OS-RC-2 and RCC10RGB were obtained from RIKEN
(Tokyo, http://www.riken.go.jp/). DU145 and MCF-7 were
obtained from the American Type Culture Collection
(ATCC; Manassas, VA, http://www.atcc.org/), and the other
cell lines were obtained from the Health Science Research
Resources Bank (HSRRB; Tokyo, http://www.jhsf.or.jp/).
2.2.SPCellAnalysisandCellSorting. Thecellsweredetached
from the dishes with 0.05% Trypsin EDTA (Gibco) and
resuspended at 2 ×106 cells/mL in DMEM/F12 (Gibco) with
2% FBS. The cell suspensions were incubated with 5μg/mL
Hoechst33342 (Sigma-Aldrich) for 60 minutes at 37◦C. To
conﬁrm the SP population, an aliquot was stained with
Hoechst33342inthepresenceof50μMofreserpine(Daiichi-
sankyo,Tokyo).BothVerapamilandreserpinearecommonly
used for inhibiting the ABC transporter in SP analyses [23],
but reserpine was more eﬀective for SP analysis under our
staining conditions. The cells were resuspended in Hank’s
balanced salt solution (Gibco) supplemented with 0.2% FBS
containing 7AAD (BD Biosciences, San Diego) at a ﬁnal
concentration of 0.25μg/mL to enable the discrimination of
dead cells. Cell analysis and sorting were performed using a
FACS Vantage (BD Biosciences). Hoechst33342 was excited
at 400nM, and ﬂuorescence emission was detected using a
424/44 BP and 585/42 BP optical ﬁlter for Hoechst blue and
Hoechst red, respectively, and a 510-nm long-pass dichroic
mirror to separate the emission wavelengths. Both Hoechst
blue and red ﬂuorescence were displayed using a linear scale.
7AAD ﬂuorescence was measured using a 675/20 BP after
excitation at 499nM with an argon laser.
2.3. Drug Sensitivity Assay. Sorted NEC8 SP and non-SP
cells were seeded at a density of 3 × 103 cells into 96-
well plates containing 100μL per well of the appropriate
growth medium. The plates were then incubated at 37◦Ci na
humidiﬁed air atmosphere containing 5% CO2 for 48 hours.
The cells were treated with cisplatin (0.01 to 10μM) for 2
hours. After another 120 hours, the viability of the cells was
measured using a colorimetric water-soluble tetrazolium salt
assay (Cell Counting Kit-8, CCK-8), (Dojindo, Kumamoto,
Japan, http://www.dojindo.co.jp/) according to the manu-
facturer’s instructions, and the colorimetric analysis was
detected using ARVO SX (Perkinelmer, Boston).
2.4. Invasion Assay. BD BioCoat Matrigel 24-well invasion
chambers (BD Biosciences) were used according to the
manufacturer’sinstructions.Cellswereseededintotheupper
inserts at a density of 1.5 × 105 per insert in serum-free
RPMI1640. A culture medium containing 10% FBS was used
as a chemoattractant in the lower wells. After 48 hours, the
noninvaded cells on the upper surfaces of the membranes
were removed using a cotton swab. Then, the membranes
were ﬁxed with 100% methanol and stained using Giemsa
dye.Theinvasivenessofthecellswasdeterminedbycounting
the number of cells that had penetrated through the pores
and onto the lower side of the membrane using a microscope
at a magniﬁcation of ×100. The number of cells that had
migrated through the Matrigel was normalized by the mean
cell count of the cells treated with NSC siRNA that were used
in each invasion experiment. The invasiveness was expressed
as the mean number of cells in ﬁve randomly selected
ﬁelds. The percentage of invasion was determined as follows:Stem Cells International 3
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Figure 1:RepresentativeFACSanalysisofsidepopulationcellsinhumancancercelllines.Caki1andLNCapcellsareshownasrepresentative
negative results. The SP fractions in NEC8 and MCF7 were 3.7% and 0.7%, respectively. The SP fractions disappeared in the presence of
reserpine (bottom panels).
%i n v a s i o n= mean number of cells invading through the
Matrigel insert membrane/mean number of cells migrating
through the control insert membrane [24]. The assays was
carried out as three independent experiment.
2.5. RNA Extraction and Oligonucleotide Microarray
Analysis. Total RNA was extracted from the NEC8 SP and
non-SP cells using TRIZOL (Invitrogen, Carlsbad, CA,
http://www.invitrogen.com) according to the manufacturer’s
protocol. The purity of the RNA was checked using an
Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto,
CA). We used the Human Genome U133A Plus2.0 arrays
(Aﬃmetrix, Santa Clara, CA), which contain almost 54,000
probe sets representing more than 47,000 transcripts includ-
ing 38,500 well-characterized human genes. The preparation
of the cRNA and the hybridization of the probe arrays were
performed according to the protocols of the manufacturer.
2.6. Real-Time Quantitative PCR Analysis. Total RNA was
extracted from SP and non-SP cells using an RNeasy
Mini Kit (Qiagen, Valencia, CA, http://www1.qiagen.com)
accordingtothemanufacturer’sprotocol.cDNAwasreverse-
transcribed from total RNA (20ng) using a High Capac-
ity cDNA Archive Kit (Applied Biosystems, Foster City,
CA, https://www2.appliedbiosystems.com)a n dR Tr e a c t i o n s
were performed in a GeneAmp PCR System 9700 thermal
cycler (Applied Biosystems). TaqMan polymerase chain
reaction (PCR) was carried out with the TaqMan Universal
PCR master mix (Applied Biosystems) and TaqMan Gene
expression assay (Applied Biosystems) according to the man-
ufacturer’s instructions. PCR ampliﬁcation was performed
using a 7500 Real-Time PCR System (Applied Biosystems).
The TaqMan primer IDs for each of the analyzed genes
were as follows: ABCG2, Hs00184979 g1; GADD45β ,
Hs00169587 m1; and GAPDH, Hs99999905 g1.
2.7. siRNA Duplexes and Transfection. All siRNA duplexes
were purchased as HP Genome Wide siRNA from Qiagen
and transfected using HiPerFect (Qiagen). ABCG2 siRNA
(50nM) and GADD45β siRNA (50nM) were transfected 24
hours after seeding. The cells were exposed to cisplatin 48
hours after seeding.
3. Results
3.1. SP Phenotype in Human Cancer Cell Lines. We per-
formed a ﬂow cytometry analysis using Hoechst 33342
dye staining (SP cell analysis) in 12 human cancer
cell lines (ACHN, Caki-1, OS-RC-2, RCC10RGB, DU145,
LNCap.FGC, PC3, EJ-1, RT4, T24, NEC8, and MCF7)
(Figure 1). The SP gate was deﬁned as the diminished region
in the presence of reserpine, which blocked the activity of the
Hoechst 33342 dye transporter. The SP fraction in MCF7 has
a l r e a d yb e e nr e p o r t e d[ 23], and we used MCF7 as a positive
control for the gating. However, we conﬁrmed an SP fraction
onlyinNEC8andMCF7,rangingfrom0.7%to3.7%,among4 Stem Cells International
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Figure 2: Cell growth and Cisplatin resistance. (a) Growth curve of NEC8 SP (black circles) and non-SP (black squares) cells. (b)
Concentration response curve of cell viability after cisplatin treatment. Cell viability is shown as a percent of the control (no treatment).
Values are the means ± SD (n = 8). ∗P<.01, signiﬁcant diﬀerence versus non-SP.
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Figure 3: Invasion assay. (a) Representative photograph of Matrigel invasion assay. Scale bar = 50μm. (b) Comparison of invasiveness of
NEC8 SP and non-SP cells. The invaded cell counts from triplicate invasion assays of three independent experiments are shown. Values are
the % mean ± SD (n = 8). ∗P<.05 versus non-SP.
the 12 human cancer cell lines using our Hoechst 33342 dye
staining condition (60 minutes).
3.2. Growth and Chemoresistance of Cancer SP. Although we
could not ﬁnd any morphological diﬀerence in the FACS-
sorted NEC8 SP cells and non-SP cells, we next compared
the cell growth and chemoresistance of these 2 fractions.
Although no diﬀerence was observed until 72 hours after
seeding, the NEC8 SP cells showed rapid cell growth,
compared to the non-SP cells, after 96 hours (Figure 2(a)).
To examine the chemoresistance of NEC8 SP cells, cell
viability was examined in the presence of cisplatin (0.01μM
to 50μM). Compared with the non-SP cells, the SP cells
showed a signiﬁcantly higher resistance to cisplatin, ranging
from 0.01μMt o1 . 0μM( Figure 2(b)).
3.3.StrongInvasivenessinSPCells. Toclarifythediﬀerencein
invasiveness between SP and non-SP cells, we performed an
in vitro Matrigel invasion assay. NEC8 non-SP cells showed
almost no invasion. However, NEC8 SP cells showed a level
of invasiveness that was approximately 10 times greater than
that of the non-SP cells (Figure 3).
3.4. SP Cells Regenerate Both SP and Non-SP Cells. To
investigate the repopulation ability of NEC8 SP cells, we
cultured FACS sorted cells for ﬁve days and performed a
second SP analysis again. The NEC8 SP cells generated both
SP and non-SP cells, with an SP fraction size that was greater
than that of the original population (4.3% versus 13.0%;
Figure 4).Stem Cells International 5
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Figure 4: SP cells from NEC8 become SP and non-SP cells. Hoechst 33342 dye-stained NEC8 cells were sorted to extract the SP fraction
(upper panel), and the SP fraction was further cultured. On day 5, the cultured cells were stained with Hoechst 33342 and reanalyzed (lower
panel).
3.5. Gene Expression Proﬁle of SP Cells Using a Microarray
Analysis. To investigate the gene expression proﬁle of SP
cells, we performed an oligonucleotide-based DNA microar-
ray analysis using a GeneChip Human Genome U133 Plus
2.0 array (Aﬀymetrix). We searched for genes with a high
signal intensity (more than 100) and signiﬁcant diﬀerences
in expression (SP/non-SP > 1.8 or non-SP/SP > 1.8).
Moreover, we selected genes that were expressed in both
NEC8 SP cells and MCF7 SP cells. Among 38,500 genes,
we identiﬁed 12 genes that were overexpressed in SP cells
and 1 gene that was overexpressed in non-SP cells (Table 1).
Unexpectedly, ABCG2, which determines the SP phenotype,
was not included in this table (its SP/non-SP ratio was
slightly less than 1.8), but we conﬁrmed that ABCG2 was
overexpressed in the SP cells using real-time PCR (Figures
5(c) and 5(d)). Among the 13 genes, we focused on
GADD45β, an essential mediator of cell survival in cancer
cells, that was overexpressed in non-SP cells using three
diﬀerent microarray probes (Figures 5(a) and 5(b)). The
over-expression of GADD45β in non-SP cells was conﬁrmed
using real-time PCR (Figures 5(c) and 5(d)).6 Stem Cells International
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Figure 5: Gene expression proﬁle of SP cells according to a microarray and real-time PCR analysis. (a and b) Scatter plot analyses of gene
expressioninSPversusnon-SPcellsfromNEC8(a)andMCF7(b).ABCG2isshownbythegreenarrow,andGADD45β isshownbythegray
arrow. (c and d) Quantitative gene expression analysis of ABCG2 and GADD45β (normalized to GAPDH) using real-time PCR in NEC8 (c)
and MCF7 (d). Values are the mean ± SD (n = 8). P∗ <. 05 versus non-SP cells.
3.6. Paradoxical Functional Role of ABCG2 and GADD45β
in SP Cells. To clarify the functional roles of ABCG2 and
GADD45β in NEC8 SP cells, we treated the NEC8 SP
and non-SP cells with small interfering RNA (siRNA) of
the genes and examined cell viability in the presence and
absence of cisplatin (0.1μM). Compared to treatment with
nonsilencing control siRNA, treatment with siRNA for
ABCG2 and GADD45β signiﬁcantly reduced gene expres-
sion in both NEC8 SP and non-SP cells (Figures 6(a)
and 6(b)). Treatment with siRNA for ABCG2, which is
overexpressed in NEC8 SP cells, signiﬁcantly reduced the cell
viability of NEC8 SP cells but had no eﬀect on the non-
SP cells (Figures 6(c) and 6(d)). Paradoxically, treatment
with siRNA for GADD45β, which is overexpressed in non-
SP cells, signiﬁcantly reduced the cell viability of SP cells
but had no eﬀect on the non-SP cells (Figures 6(c) and
6(d)).
3.7. GADD45β Determines the Invasiveness of SP Cells, But
Not the SP Phenotype. As shown in Figure 3, the SP cells
showed a very strong invasiveness, compared with the non-
SP cells. To clarify the mechanism of invasiveness, we treated
the NEC8 SP cells with siRNA for ABCG2 and GADD45β.
Although treatment with siRNA for ABCG2 signiﬁcantly
reduced gene expression (Figure 6(a)), it showed no eﬀect
on invasion (Figure 7(a) upper middle and Figure 7(b)).
On the other hand, treatment with siRNA for GADD45β
signiﬁcantly prevented invasion (Figure 7(a) upper right
and Figure 7(b)). As GADD45β belongs to the growth
arrest- and DNA damage-inducible protein family, we tried
to upregulate GADD45β in NEC8 by treating the cells
with a low concentration of cisplatin (0.01μMf o r2 4
hours). The NEC8 cells were incubated with the vehicle or
cisplatin for 24 hours, and were then sorted using FACS.
Treatment with a low concentration of cisplatin (0.01μM)
signiﬁcantly upregulated the gene expressions of GADD45β
in NEC8 SP cells, but showed no eﬀect on non-SP cells
(Figure 7(c)). Although treatment with a low concentration
of cisplatin upregulated the expression of GADD45β in SP
cells (Figure 7(c)),anFACS analysisshowednochangeinthe
SP population (Figure 7(d)).Stem Cells International 7
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Figure 6: Functional roles of ABCG2 and GADD45β in NEC8 SP and non-SP cells. (a and b) Quantitative gene expression analysis of
ABCG2 and GADD45β after treatment with siRNA in NEC8 SP cells (a) and non-SP cells (b). The white bar represents treatment with
nonsilencing control siRNA (NSC) and the black bar represents ABCG2 siRNA and GADD45β siRNA. (c and d) Eﬀect of treatment with
siRNA for ABCG2 and GADD45β on cell viability. The white bar represents the untreated control, the gray bar represents treatment with
NSC, and the black bar represents treatment with siRNA. The values are shown as the percent of the untreated control. ∗P<. 001 versus
NSC.
4. Discussion
The SP phenotype can be used to enrich a stem cell
fraction and is determined by the presence of ABCG2 [5].
However, the physiological role of this ATP binding cassette
transporter in cancer SP cells is still unclear. In this study,
we conﬁrmed the signiﬁcant existence of SP cells in a
human embryonic carcinoma cell line, NEC8. NEC8 SP
cells showed cancer stem-like phenotypes, such as rapid
growth, chemoresistance, invasive growth and self-renewal.
Interestingly our results showed that GADD45β,b u tn o t
ABCG2, might determine resistance to cisplatin and the high
level of invasiveness of NEC8 SP cells.
ABCG2 is a member of the ABC transporters and is
known to transport anticancer drugs such as doxorubicin,
daunorubicin, mitoxantrone, and topotecan. GADD45β
belongs to the growth arrest- and DNA damage-inducible
protein family, and Zerbini et al. reported that the GADD45
family are essential mediators of cell survival in cancer cells,
with implications for cancer chemotherapy and novel drug
discovery [22]. In other words, both genes can protect cells
from cell death. In fact, the inhibition of these genes using
siRNA induced cell death in NEC8 SP cells. GADD45β was
overexpressedinnon-SPcells,comparedwithNEC8SPcells,
but the inhibition of GADD45β paradoxically reduced cell
viability and augmented sensitivity to cisplatin in SP cells
but not in non-SP cells. Moreover, a low dosage of cisplatin
upregulated the expression of GADD45β in SP cells, but not
in non-SP cells. These results suggest that the regulation and
functional role of GADD45β diﬀe r sa m o n gc e l lt y p e sb u t
that GADD45β could be useful for curative therapy targeting
cancer stem-like cells, such as SP cells. The inhibition of
ABCG2, which determines the SP phenotype, had no eﬀect
on the invasion of SP cells, but that of GADD45β strongly
inhibited it. Caution is needed in interpreting the eﬀects of
the knock-down of these two proteins. As NEC8 SP cells
showedrapid growthcomparedwithnon-SPcells,theeﬀects
of siRNA might be augmented by a rapid cell cycle in NEC8
SP cells, and not by the ABCG2-determined SP phenotype
itself. Although the SP population is heterogeneous, our
results suggest that there might be some hierarchy of genes
that determines the various phenotypes of SP cells. ABCG2
might determine the general common phenotype of SP cells,
while GADD45β might determine part of the core functions
of these cells, such as chemoresistance and invasiveness.
In this study, we examined 12 cancer cell lines (ACHN,
Caki-1, OS-RC-2, RCC10RGB, DU145, LNCap.FGC, PC3,
EJ-1, RT4, T24 and NEC8) and found SP cells only in NEC8.
However, Patrawala et al. and Ning et al. have reported SP
cells or stem-like populations in these cell lines [23, 25, 26].8 Stem Cells International
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Figure 7: GADD45β determines invasion of SP cells but not SP phenotype. (a) Representative photographs of invasion of NEC8 SP cells
after the inhibition of ABCG2 and GADD45β using siRNA. Scale bar = 50μm. (b) Comparison of invasiveness of NEC8 SP cells treated
with siRNA. Values are the means of the normalized cell counts to NSC from triplicate invasion assays of three independent experiments.
∗P<. 005 versus NSC. NSC means treatment with nonsilencing control siRNA, G means treatment with GADD45β siRNA, and A means
ABCG2 siRNA. ∗P<. 001 versus NSC. (c) Upregulation of GADD45β by treatment with a low concentration of cisplatin. NEC8 cells were
incubated with vehicle (cont) or 0.01μM of cisplatin (cis) for 24 hours, and were sorted by FACS. The gene expression of GADD45β in SP
(black bar) and non-SP (white bar) cells was evaluated using real-time PCR. The values are the mean ± SD (n = 8). ∗P<. 001 versus non-SP
(n = 8). (d) SP analysis after the upregulation of GADD45β. NEC8 cells were incubated with the vehicle (cont) or 0.01μM of cisplatin (cis)
for 24 hours, and an SP analysis was performed in the presence (white bar) or absence (black bar) of reserpine. Values are the mean ± SD
(n = 8). NS means not signiﬁcant.
We believe that diﬀerences in the staining conditions of their
studies and ours might explain this discrepancy. Patrawala
et al. [25] stained cancer cells with CD44&α2β1 or stained
cells with Hoechst 33342 for 90 minutes [23]. Ning et al.
[26] also stained cells with Hoechst 33342 for 90 minutes,
but our incubation time was 60 minutes. Generally, a long
incubation time increases the SP population. However, a
long incubation time (90minutes) somehow reducedthecell
viability of NEC8, and we optimized our incubation time as
60 minutes. We believe that discussing the deﬁnite existence
of small SP populations is diﬃcult without standardizing the
staining condition. Further studies are required to optimize
the staining conditions, but we believe that SP analysis
in cancer cells can be useful for predicting some disease
characteristics that might be suitable treatment targets.
Zhou et al. reported that the stem-like phenotype of SP
cellsisdeterminedbyABCG2[5].Wealsofoundasigniﬁcant
diﬀerence in the gene expression of ABCG2 in NEC8 SP
and non-SP cells, but the diﬀerence was marginal. As the
SP fraction was separated according to the functional dye-
eﬄux capacity of ABCG2, we speculate that there might be
a discrepancy between the gene expression of ABCG2 and
the functional capacity of ABCG2 in NEC8 SP cells, and an
alternative criteria for identifying CSC should be considered
forNEC8SPcells.Noprecisecriteriaexistfordeﬁningcancer
stem cells, but several reports have proposed two major
characteristics of CSC [1, 2, 27–30]: (1) an everlasting period
of self-renewal (tumorigenesis), and (2) the production of
progenitor cells through heterogeneous division with the
ability to further diﬀerentiate. Moreover, some other reports
havementionedresistancetocancertherapydrugsasanother
characteristic [2, 27, 28]. In the medical literature, cancer
SP cells reportedly show the ability to undergo multilineage
diﬀerentiation both in vivo and in vitro [15–20]. In our
study, NEC8 SP cells showed the ability to undergo self-
renewal and exhibited resistance to cancer therapy drugs. To
further clarify the cancer stem-like character of NEC8 SP
cells, we used a xenograft model using SCID-mice, CD 133
staining [31] and sphere formation. However, we found no
diﬀerences between the NEC8 SP cells and the non-SP cells.
Our results were not suﬃcient to characterize NEC8 SP cells
as cancer stem-like cells, but these cells might be a usefulStem Cells International 9
Table 1
Probe Set lD Gene symbol Gene name Unigene SP/Non SP signal SP/Non SP signal
(NEC8) (MCF7)
SP < non-SP
207574 s at GADD45β growth arrest and dna-damage-inducible, beta Hs.110571 305.9/594.6 272.2/489.9
209304 x at 126./249.5 121/241.6
SP > Non SP
203002 at AMOTL2 Kiaa0989 protein Hs.426312 244.7/105.2 289.8/240.5
202464 s at PFKFB3 6-phosphofructo-2-kinase/frucrose-2, 6-biphosphatase 3 Hs.195471 343.4/164.1 502.3/177.5
232889 at LOCI53561 Hypothetical protein loc153561 Hs.283742 277.3/152.4 455.5/92.6
232174 at EXT1 Exostoses (multiple) 1 Hs.492618 430.2/177.2 224/68.2
201631 s at IER3 Immediate early response 3 Hs.76095 2249.9/960.6 3962.7/2442
221215 s at RIPK4 Rceptor-interacting serine-threonine kinase 4 Hs.517310 1517.6/517.8 291.9/118.8
234981 x at LOCI34147 Smilar to mouse 2310016a09rik gene Hs.I92586 1382.6/660 1566.5/989.1
209501 at CDR2 Crebellar degeneration-related protein 2 Hs.513430 355.8/187.8 307.2/123.3
202431 s at MYC v-myc myclocytomatosis viral oncogene homolog (avian) Hs.202453 1468.1/355.3 1832/599.2
220796 x at SLC35E1 Slute carrier family 35, member el Hs.134074 488.5/262.8 832.3/218.3
201694 s at EGRI Erly growth response 1 Hs.326035 1412/576.2 808.3/415
1562062 at NBPF Nuroblastoma breakpoint family, member Hs.351620 286.6/141.1 230.4/47.4
1562063 x at 1,3,8,9,10,11,20 320.2/126.7 301.7/106
therapeutictargetastheyshowedresistancetocancertherapy
and are highly invasive.
In conclusion, our results showed that cancer cells are
not homogeneous and suggest that therapeutic strategies
targeting speciﬁc cell populations, such as SP cells and non-
SP cells, should be considered. The CSC-like phenotype of
cancer SP cells might not only be determined by ABCG2,
but also by GADD45β. Although SP cells comprise a minor
population of all cancer cells, it is very important to
completely kill these cells to achieve a curative therapy, since
SP cells exhibit a strong resistance to cancer therapy and are
highly invasive. Taken together, our results suggest that the
inhibition of both ABCG2 and GADD45β might be used
as a new target for curative therapy without recurrence or
metastasis through the targeting of cancer stem-like cells,
such as SP cells.
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